Comparison of Success Rates Between Laser Photocoagulation and Intravitreal Anti-Vascular Endothelial Growth Factor Injection for the Treatment of Retinopathy of Prematurity in a Tertiary Referral Center: An 11-Year Survey.

The overall reactivation rate for retinopathy of prematurity after treatment was 6.5% (n=28).

The reactivation rates for group 1 and group 2 were 3.7% (n=11) and 12.6% (n=17), respectively, with the difference being significant (p<0.001).

Low birth weight, low gestational age, and aggressive posterior retinopathy of prematurity were identified as factors contributing to an elevated risk of reactivation.

The median time to reactivation was similar for both group 1 and group 2 patients (p>0.05).